ATNM:Actinium Pharmaceuticals Inc Snapshot | Charting | News | Options
$1.40 NYSE MKT LLC 5:05p ET
September 4 '26 		Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference PR Newswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
     PR Newswire

    Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced that Sandesh Seth, Chairman and Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference, being held September 14-16, 2026, in New York, NY. Company management will also be available for one-on-one meetings with investors.

    Full Story →

    Headline News
    Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update
    5:02p ET August 14 '26 PR Newswire
    Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update
    5:02p ET August 14 '26 PR Newswire
    More News →
    Day  6.87%Week  35.9%Month  45.2%More Charting →
    September 11 '26. Markets Closed.
    Last $1.40
    Day change   6.87%$0.09
    Open $1.31
    Gap at open $0.00
    Previous close $1.31
    Trading volume 242,659
    10 Day avg vol. 179,758
    Shares out. 31.4Mil
    Market cap. $44.0Mil
    Trading activity Above Avg.
    Previous data from yesterday, September 10 '26.

    Historical Price Performance
    3 month   38.61% 
    6 month   26.13% 
    1 year   14.11% 
    2 year   28.57% 

    Earnings
    Previous 12m $0.36
    Next 12m Estimate -$0.23
    P/E ratio 3.9x
    Revenue 35Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.